Cargando…

Dopamine transporter changes after unilateral deep brain stimulation in progressive Parkinson’s disease: a case report

Deep brain stimulation (DBS) at the subthalamic nucleus has been approved as an effective treatment for refractory symptoms of Parkinson’s disease (PD). Studies have shown that bilateral DBS surgery in PD patients results in clinical improvement without reducing dopamine transporter function. Here,...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Huiwei, Wang, Yuanyuan, Liang, Jinchuan, Förster, Stefan, Wu, Ping, Zhao, Jun, Guan, Yihui, Zuo, Chuantao
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2014
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3986415/ https://www.ncbi.nlm.nih.gov/pubmed/24748796 http://dx.doi.org/10.2147/NDT.S59739

Ejemplares similares

Metabolic network as an objective biomarker in monitoring deep brain stimulation for Parkinson’s disease: a longitudinal study
por: Ge, Jingjie, et al.
Publicado: (2020)

Decoding the dopamine transporter imaging for the differential diagnosis of parkinsonism using deep learning
por: Zhao, Yu, et al.
Publicado: (2022)

Increased Vesicular Monoamine Transporter 2 (VMAT2) and Dopamine Transporter (DAT) Expression in Adolescent Brain Development: A Longitudinal Micro-PET/CT Study in Rodent
por: Jiang, Donglang, et al.
Publicado: (2019)

The Parkinson's Disease Progression Neuroimaging Initiative
por: Zhu, Shiyi, et al.
Publicado: (2021)

Brain Functional and Structural Signatures in Parkinson’s Disease
por: Liu, Chunhua, et al.
Publicado: (2020)

Brain Network and Abnormal Hemispheric Asymmetry Analyses to Explore the Marginal Differences in Glucose Metabolic Distributions Among Alzheimer's Disease, Parkinson's Disease Dementia, and Lewy Body Dementia
por: Chen, Danyan, et al.
Publicado: (2019)

Clinical factors and dopamine transporter availability for the prediction of outcomes after globus pallidus deep brain stimulation in Parkinson’s disease
por: Lee, Seung Hyun, et al.
Publicado: (2022)

Dopamine Dysregulation Syndrome and Deep Brain Stimulation of the Subthalamic Nucleus in Parkinson's Disease
por: De la Casa-Fages, Beatriz, et al.
Publicado: (2011)

Substantia nigra micro-haemorrhage causing ipsilateral unilateral Parkinsonism and abnormal dopamine transporter scan uptake
por: Ghoneim, Aliaa, et al.
Publicado: (2020)

Anatomical Correlates of Uncontrollable Laughter With Unilateral Subthalamic Deep Brain Stimulation in Parkinson’s Disease
por: Huang, Yonglu, et al.
Publicado: (2018)

Comparison of subthalamic unilateral and bilateral theta burst deep brain stimulation in Parkinson’s disease
por: Gülke, Eileen, et al.
Publicado: (2023)

Imaging of dopamine transporters in Parkinson disease: a meta‐analysis of (18)F/(123)I‐FP‐CIT studies
por: Kong, Yanyan, et al.
Publicado: (2020)

Dual-Model Radiomic Biomarkers Predict Development of Mild Cognitive Impairment Progression to Alzheimer’s Disease
por: Zhou, Hucheng, et al.
Publicado: (2019)

Asymmetric Dopamine Transporter Loss Affects Cognitive and Motor Progression in Parkinson's Disease
por: Fiorenzato, Eleonora, et al.
Publicado: (2021)

Does the Personality of Patients with Parkinson's Disease Affect the Decision to Perform Deep Brain Stimulation Surgery? A Cross-Sectional Study in a Chinese Cohort
por: Lin, Wei, et al.
Publicado: (2021)

In Vivo Tau Burden Is Associated with Abnormal Brain Functional Connectivity in Alzheimer’s Disease: A (18)F-Florzolotau Study
por: Ju, Zizhao, et al.
Publicado: (2022)

Refining diagnosis of Parkinson's disease with deep learning-based interpretation of dopamine transporter imaging
por: Choi, Hongyoon, et al.
Publicado: (2017)

Bupropion Causes Misdiagnosis in Brain Dopamine Transporter Imaging for Parkinsonism
por: Honkanen, Emma A., et al.
Publicado: (2019)

Five-year follow-up of 23 asymmetrical Parkinson's disease patients treated with unilateral subthalamic nucleus stimulation★
por: Liang, Jinchuan, et al.
Publicado: (2012)

Corrigendum to “Does the Personality of Patients with Parkinson's Disease Affect the Decision to Perform Deep Brain Stimulation Surgery? A Cross-Sectional Study in a Chinese Cohort”
por: Lin, Wei, et al.
Publicado: (2021)

Effect of Deep Brain Stimulation on Parkinson's Nonmotor Symptoms following Unilateral DBS: A Pilot Study
por: Hwynn, Nelson, et al.
Publicado: (2011)

Differential cognitive effects of unilateral left and right subthalamic nucleus deep brain stimulation for Parkinson disease
por: Del Bene, Victor A, et al.
Publicado: (2023)

Validation of abnormal glucose metabolism associated with Parkinson’s disease in Chinese participants based on 18F-fluorodeoxyglucose positron emission tomography imaging
por: Jin, Rongbing, et al.
Publicado: (2018)

Coordinate based meta-analysis of motor functional imaging in Parkinson’s: disease-specific patterns and modulation by dopamine replacement and deep brain stimulation
por: Xing, YUE, et al.
Publicado: (2019)

Dopamine Transporter Genetic Variants and Pesticides in Parkinson’s Disease
por: Ritz, Beate R., et al.
Publicado: (2009)

The metabolic brain network in patients with Parkinson's disease based on (18)F-FDG PET imaging: evaluation of neuronal injury and regeneration
por: Ge, Jingjie, et al.
Publicado: (2014)

Deep brain stimulation in Parkinson’s disease
por: Mehanna, Raja, et al.
Publicado: (2013)

Deep Brain Stimulation in Parkinson's Disease
por: Mehanna, Raja, et al.
Publicado: (2018)

Deep brain stimulation for Parkinson's disease
por: Hariz, Marwan, et al.
Publicado: (2022)

Dopamine transporter binding in the brain is linked to irritable bowel syndrome in Parkinson's disease
por: Murtomäki, Kirsi, et al.
Publicado: (2023)

Clinical effectiveness of unilateral deep brain stimulation in Tourette syndrome
por: Kuhn, J, et al.
Publicado: (2011)

The Study of Subthalamic Deep Brain Stimulation for Parkinson Disease-Associated Camptocormia
por: Liang, Siquan, et al.
Publicado: (2020)

Radiomics: a novel feature extraction method for brain neuron degeneration disease using (18)F-FDG PET imaging and its implementation for Alzheimer’s disease and mild cognitive impairment
por: Li, Yupeng, et al.
Publicado: (2019)

Dopamine Transporter Imaging in Parkinson Disease: Progressive Changes and Therapeutic Modification after Anti-parkinsonian Medications
por: Ikeda, Ken, et al.
Publicado: (2019)

Neuropeptide Y Plays an Important Role in the Relationship Between Brain Glucose Metabolism and Brown Adipose Tissue Activity in Healthy Adults: A PET/CT Study
por: Zhang, Qiongyue, et al.
Publicado: (2021)

Dopamine Transporter Loss in 6-OHDA Parkinson’s Model Is Unmet by Parallel Reduction in Dopamine Uptake
por: Chotibut, Tanya, et al.
Publicado: (2012)

Association of the dopamine transporter gene with Parkinson's disease in Korean patients.
por: Kim, J. W., et al.
Publicado: (2000)

Dopamine transporter SPECT imaging in Parkinson’s disease and parkinsonian disorders
por: AKDEMİR, Ümit Özgür, et al.
Publicado: (2021)

Gastrointestinal Symptoms and Dopamine Transporter Asymmetry in Early Parkinson's Disease
por: Murtomäki, Kirsi, et al.
Publicado: (2022)

Individual brain metabolic connectome indicator based on Kullback-Leibler Divergence Similarity Estimation predicts progression from mild cognitive impairment to Alzheimer’s dementia
por: Wang, Min, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_17ntdvcs7kh693afb9am7hq7ng